Optinose to Present at the Cantor Virtual Global Healthcare Conference
September 22, 2021 16:15 ET
|
Optinose, Inc.
YARDLEY, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose to Present at the Needham Virtual Healthcare Conference
April 12, 2021 16:15 ET
|
Optinose, Inc.
YARDLEY, Pa., April 12, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Peter Miller Named Frank Baldino Bioscience CEO of the Year by Life Sciences Pennsylvania
February 20, 2018 16:01 ET
|
OptiNose, Inc.
YARDLEY, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...